Contact this trialFirst, we need to learn more about you.
Anti-tumor antibiotic
Gemcitabine + Docetaxel for Bladder Cancer
Recruiting3 awardsPhase 2
Baltimore, Maryland
This trial is testing a new combination therapy for bladder cancer that has not yet been proven safe or effective. If the new therapy is found to be both safe and effective, it could become the new standard of care.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.